Identification of HSPG2 as a bladder pro-tumor protein through NID1/AKT signaling
This study highlights the critical pro-tumor role of HSPG2/NID1/AKT signaling in bladder cancer and suggests its potential as a therapeutic target in clinical treatment.
Authors
- Fengzhu Guo (ORCID: https://orcid.org/0000-0002-0478-9315)
- Min Shen (ORCID: https://orcid.org/0000-0003-1125-5001)
- Peng-Wei Luo
- Ting Du (ORCID: https://orcid.org/0000-0002-9020-3746)
- Cong Li (ORCID: https://orcid.org/0000-0001-6986-629X)
- Ting Zhang (ORCID: https://orcid.org/0000-0002-2862-7644)
- Jia Xu
- Shusen Wang
Institutions
- Sun Yat-sen University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- First Affiliated Hospital of Chengdu Medical College (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Cancer Cell International
- Published
- 2024-10-23
- DOI
- https://doi.org/10.1186/s12935-024-03527-7
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation